Spots Global Cancer Trial Database for A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.

Official Title: A Randomized Clinical Trial With a New Needle Device Comparing 25G and 22G Needle in Endoscopic Ultrasound Fine-needle Aspiration of Solid Lesions.

Study ID: NCT02246322

Conditions

Pancreatic Cancer

Neuroendocrine Tumors

Lymphadenopathies

GIST

Gastric Wall Tumor

Interventions

25G needle

22G needle

Study Description

Brief Summary: Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) is a reliable, safe, and effective technique for obtaining samples from the GI wall lesions and from organs adjacent to the GI tract (pancreas, nodes...).Needles available for EUS-FNA include 25G, 22G and 19G. Some studies have suggested that the 25G needle could be equal or even better than the 22G needle. The BXN system and neddles are is a newly developed for EUS-FNA. This trial is developed for testing the accuracy of the new neddle system for EUS-FNA and for comparing the two needles types, 25G and 22G.

Detailed Description: